Bausch + Lomb Corporation (NYSE:BLCO; TSX:BLCO), a global eye health company, has been navigating a complex market landscape ...

The series is expected to include four smartphones: the Galaxy S25, Galaxy S25+, Galaxy S25 Ultra, and the Galaxy S25 Slim. Listen to Story Samsung to unveil Galaxy S25 series on Jan 22 Prices higher ...

Bausch + Lomb will manage IND-enabling studies, clinical development, regulatory submissions, and commercialization if they pursue the candidate. City Therapeutics retains technology rights, with ...

Summary: New research demonstrates that high-add multifocal contact lenses significantly slow myopia progression in children, with benefits that persist even after discontinuation. The lenses, ...

Brent Saunders, Bausch and Lomb CEO, joins 'Money Movers' to discuss how Saunders has changed the portfolio in his time as chief executive, what the growth is like for Bausch and Lomb, and much more.

In the US, enVista Aspire is the first Low-Cyl toric IOL below 1.5D at the IOL plane, enhancing treatment options. Bausch + Lomb announced the commercial launch of its enVista Aspire monofocal and ...

London, UK, 13 January 2025 – George Medicines, a late-stage biopharmaceutical company focused on addressing significant unmet needs in cardiometabolic disease, has entered into an exclusive licensing ...

Renders suggest that the Galaxy S25 Ultra may feature curved edges All Galaxy S25 models are expected to run Android 15-based One UI 7 Samsung will launch the devices at Galaxy Unpacked event on ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the commercial launch of the enVista Aspire ...

VAUGHAN, Ontario--(BUSINESS WIRE)-- Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the ...